About Rebekah Gossom
Form D filings for Innovative Therapeutix from 2022 to 2023 list Rebekah Gossom as director.
Rebekah Gossom first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Rebekah Gossom in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rebekah Gossom works with at each company, as listed on that company's latest Form D.
Innovative Therapeutix, Inc. · Form D, Jan 5, 2023
RS
Robert Saunders
Director
MD
Michael Detmer
Chief Executive Officer and director